Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.107 (
DAT
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A study of several elements of the antioxidative system: Cu-Zn superoxide dismutase (SOD), catalase (CAT), glutathione system (GLU), chemiluminescence (CHE), and antioxidant capacity (
AOX)
, was conducted in 20 demented probable Alzheimer's (
DAT
), and 15 vascular demented (VD) patients, 19 control (C) subjects, and 11 relatives (F) of one
DAT
patient. A significant association was found between the variables of the antioxidant system, measured in blood samples, and the neurological pathologies VD and
DAT
: Kruskal-Wallis test; p = 0.0006 (p = 0.014 when the analysis did not include SOD). This demonstrated that VD and
DAT
diseases are accompanied by oxidative disorders. The VD and
DAT
diseases are differentially distinguishable by changes in blood profiles. A graphical method for classification, the Principal Components Analysis (PCA), distinguished between demented and non-demented subjects on the basis of their laboratory variables. A numerical method, Discriminant Functions (DF), constructed to separate the clinical groups on the basis of the same variables, obtained relatively high percentages of success: 92% of demented were detected against healthy subjects; of the latter 82% have been correctly identified as non-demented. Discrimination between VD and
DAT
patients was achieved for 100% of VD and 86% of
DAT
patients. DF were similarly successful in detecting the healthy condition of
DAT
relatives. Possible different mechanisms involved in H2O2 elimination in
DAT
and VD patients are proposed, where CAT is the responsible enzyme of this reaction in
DAT
patients, while in VD this function would be achieved mainly through the action of GLU. It seems that SOD levels are stable, at least, within one year. Variations appear to be linked with clinical changes.
...
PMID:The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls. 888 Jun 96